Simplex Trading’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $134K | Buy |
30,000
+26,700
| +809% | +$133K | ﹤0.01% | 4750 |
|
|
2025
Q4 | $17.4K | Sell |
3,300
-63,600
| -95% | -$320K | ﹤0.01% | 6606 |
|
|
2025
Q3 | $353K | Buy |
66,900
+31,400
| +88% | +$199K | ﹤0.01% | 4261 |
|
|
2025
Q2 | $201K | Buy |
35,500
+32,800
| +1,215% | +$187K | ﹤0.01% | 4497 |
|
|
2025
Q1 | $12K | Buy |
+2,700
| New | +$14.7K | ﹤0.01% | 6953 |
|
|
2024
Q4 | – | Sell |
-3,200
| Closed | -$20K | – | 8368 |
|
|
2024
Q3 | $20K | Sell |
3,200
-1,700
| -35% | -$8.88K | ﹤0.01% | 6657 |
|
|
2024
Q2 | $20K | Buy |
4,900
+1,600
| +48% | +$8.16K | ﹤0.01% | 6874 |
|
|
2024
Q1 | $23K | Sell |
3,300
-9,000
| -73% | -$57K | ﹤0.01% | 6971 |
|
|
2023
Q4 | $61K | Buy |
+12,300
| New | +$54.1K | ﹤0.01% | 5888 |
|
|
2021
Q4 | – | Sell |
-1,348
| Closed | -$52K | – | 10349 |
|
|
2021
Q3 | $52K | Hold |
1,348
| – | – | ﹤0.01% | 7459 |
|
|
2021
Q2 | $52K | Buy |
+1,348
| New | +$55K | ﹤0.01% | 7592 |
|
|
2021
Q1 | – | Sell |
-1
| Closed | -$4K | – | 8629 |
|
|
2020
Q4 | $4K | Sell |
1
-8
| -89% | -$273 | ﹤0.01% | 7765 |
|
|
2020
Q3 | $21K | Sell |
9
-2
| -18% | -$126 | ﹤0.01% | 6320 |
|
|
2020
Q2 | $81K | Buy |
11
+6
| +120% | +$415 | ﹤0.01% | 5012 |
|
|
2020
Q1 | $28K | Buy |
5
+2
| +67% | +$134 | ﹤0.01% | 5662 |
|
|
2019
Q4 | $26K | Buy |
3
+2
| +200% | +$141 | ﹤0.01% | 5747 |
|
|
2019
Q3 | $6K | Sell |
1
-1
| -50% | -$75 | ﹤0.01% | 6504 |
|
|
2019
Q2 | $25K | Sell |
2
-1
| -33% | -$168 | ﹤0.01% | 5421 |
|
|
2019
Q1 | $61K | Buy |
3
+1
| +50% | +$179 | ﹤0.01% | 4833 |
|
|
2018
Q4 | $39K | Sell |
2
-6
| -75% | -$1.31K | ﹤0.01% | 4759 |
|
|
2018
Q3 | $258K | Buy |
8
+1
| +14% | +$355 | ﹤0.01% | 3351 |
|
|
2018
Q2 | $265K | Buy |
7
+3
| +75% | +$1.31K | ﹤0.01% | 3161 |
|
|
2018
Q1 | $62K | Sell |
4
-7
| -64% | -$2.6K | ﹤0.01% | 2213 |
|
|
2017
Q4 | $42K | Hold |
11
| – | – | ﹤0.01% | 2610 |
|
|
2017
Q3 | $4K | Buy |
+11
| New | +$2.96K | ﹤0.01% | 4511 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | -$6K | – | 6051 |
|
|
2016
Q4 | $6K | Buy |
+1
| New | +$157 | ﹤0.01% | 4149 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$5K | – | 5280 |
|
|
2015
Q3 | $5K | Sell |
1
-1
| -50% | -$133 | ﹤0.01% | 3942 |
|
|
2015
Q2 | $15K | Buy |
+2
| New | +$300 | ﹤0.01% | 2694 |
|
Other funds holding ABEO
NCM
ACM
CCC
SCM
VCM
PBM
KCM
Simplex Trading's ABEO Position: Q1 2026 in Review
Simplex Trading reduced its Abeona Therapeutics (ABEO) stake by 68% in Q1 2026, selling an estimated $336K and leaving 31,096 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #4715.
Simplex Trading first reported a position in ABEO in Q2 2015 and has held it in 27 quarters since. The position peaked at $518K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.
- Simplex Trading held 31,096 shares of Abeona Therapeutics worth $139K as of Q1 2026.
- Simplex Trading sold 67,142 Abeona Therapeutics shares in Q1 2026, an estimated $336K.
- Abeona Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4715 holding.
- Simplex Trading first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 27 quarters since.
- Simplex Trading's Abeona Therapeutics position peaked at $518K in Q4 2025.
- 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.